By Melissa Ritti ( August 22, 2024, 21:50 GMT | Comment) -- Concerns raised by Sanofi, Sonos, the American Intellectual Property Law Association and others who support a pending petition for US Supreme Court review are “misplaced,” US Patent and Trademark Office Director Kathi Vidal told the high court yesterday. In her defense of an August 2023 ruling by the US Court of Appeals for the Federal Circuit on obviousness-type double patenting, Vidal says the “practical importance” of the question presented by Cellect LLC has been “vastly” overstated. Her view is hard to reconcile with the amount of interest the case continues to generate.US Patent and Trademark Office Director Kathi Vidal yesterday told the US Supreme Court it should deny review of an August 2023 decision which one amicus curiae said “destroyed” the ability of companies to known when their patents will expire and another said renders patent term adjustment, or PTA, a “poison pill.”...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.